Press release
Rising Bacterial Infections And The Surge In Demand For Carbapenem-Based Antibiotics Is A Driving Force In Market Expansion Emerges as a Core Driver of the Carbapenem-Based Antibiotics Market in 2025
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.What Is the Expected CAGR for the Carbapenem-Based Antibiotics Market Through 2025?
There has been a consistent growth in the size of the carbapenem-based antibiotics market in the past few years. The market size is predicted to increase from $4.6 billion in 2024 to $4.78 billion in 2025, reflecting a compound annual growth rate (CAGR) of 3.8%. The historical growth has been driven by factors such as epidemics and pandemics, surge in chronic diseases, development in healare infrastructure, fast-paced urbanization, natural catastrophes, and health crises.
What's the Projected Size of the Global Carbapenem-Based Antibiotics Market by 2029?
In the coming years, a significant surge is expected in the size of the carbapenem-based antibiotics market. It is predicted to increase to " $5.97 billion by 2029 with a compound annual growth rate (CAGR) of 5.7%. The anticipated growth in the forecast period could be due to a rise in hospital-acquired infections, the appearance of multi-drug resistant strains, an expanding elderly population, an increase in surgical procedures, spreading infectious diseases, and shifting demographics. Key trends for the forecast period involve supply chain resilience and security, the development of alternative treatments, a shift towards outpatient settings, rising knowledge about antimicrobial stewardship, and the use of precision medicine approaches.
View the full report here:
https://www.thebusinessresearchcompany.com/report/carbapenem-based-antibiotics-global-market-report
Top Growth Drivers in the Carbapenem-Based Antibiotics Industry: What's Accelerating the Market?
The escalating prevalence of bacterial infections is anticipated to fuel the expansion of the market for carbapenem-based antibiotics. Such infections are triggered by bacteria, microscopic entities that may infiltrate the human body and trigger various diseases and symptoms. These antibiotics are effective treatments for serious or multi-drug-resistant bacterial infections, covering those stemming from gram-positive and gram-negative bacteria. For example, the Centers for Disease Control and Prevention, a government agency in the US, reported in July 2024 that in 2023, 78% of all bacterial infections were diagnosed by CIDTs in the historical catchment area, of which 46% were diagnosed solely using CIDTs. Consequently, the rising prevalence of bacterial infections stimulates the expansion of the market for carbapenem-based antibiotics.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12035&type=smp
Which Emerging Trends Are Transforming the Carbapenem-Based Antibiotics Market in 2025?
The primary trend taking root in the carbapenem-based antibiotics market is the creation of innovative products by leading companies to maintain their market footing. The National Health Service, a government agency in the UK, partnered with the pharmaceutical industry to roll out an innovative antibiotic subscription scheme in August 2024 to battle antimicrobial resistance (AMR). Unveiled on August 12, 2024, this revolutionary system allows pharmaceutical manufacturers to acquire fixed yearly fees-up to £20 million per drug-uncoupled from the amount prescribed, thereby negating encouragement for excess use. Valued at roughly £1.9 billion across 16 years, the initiative seeks to spur the creation of new antibiotics by assuring financial sustainability for pharma firms. Following a successful trial phase, this initiative is now a part of the wider UK strategies to combat AMR, an issue that could potentially escalate into a major global health concern, possibly causing millions of deaths by 2050 if not countered. The NHS will give preference to products that aim at critical pathogens as identified by the World Health Organization, thus underlining its dedication to responsible antibiotic use and the advancement of antibiotic innovation.
What Are the Main Segments in the Carbapenem-Based Antibiotics Market?
The carbapenem-based antibiotics market covered in this report is segmented -
1) By Type: Meropenem, Imipenem, Doripenem, Tebipenem, Other Types
2) By Indication: Intra-abdominal Infections, Urinary Tract Infections, Pneumonia, Bacterial Meningitis, Skin And Skin Structure Infections, Acute Pelvic Infections, Prophylaxis of Surgical Site Infection, Respiratory Tract Infections, Gynecological Infections, Other Indications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Meropenem: Meropenem Injection, Meropenem and Vaborbactam Combination, Meropenem for Pediatric Use
2) By Imipenem: Imipenem and Cilastatin Combination, Imipenem and Relebactam Combination, Imipenem Monotherapy
3) By Doripenem: Doripenem Injection, Doripenem for Complicated Infections
4) By Tebipenem: Tebipenem for Oral Administration, Tebipenem Pediatric Formulations, Tebipenem for Resistant Infections
5) By Other Types: Ertapenem, Panipenem, Faropenem, Combinations with Beta-Lactamase Inhibitors
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12035&type=smp
Which Top Companies are Driving Growth in the Carbapenem-Based Antibiotics Market?
Major companies operating in the carbapenem-based antibiotics market include Pfizer Inc., Merck & Co. Inc., Fresenius Kabi LLC, GlaxoSmithKline Plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., AstraZeneca plc, Meiji Holdings Co. Ltd., Sandoz International GmbH, Sumitomo Dainippon Pharma Co. Ltd., Shionogi & Co Ltd., Aurobindo Pharma Ltd., Acurx Pharmaceuticals LLC, Daewoong Pharmaceutical Co. Ltd., CeramTec GmbH, ACS Dobfar S.p.A, JW Pharmaceutical Corp, Centrient Pharmaceuticals Co, Spero Therapeutics Inc., Kopran Limited, Savior Lifetec Corporation, Flagship Biotech International Pvt. Ltd., Iterum Therapeutics plc, Cam Carbapenem-based antibiotics BV, Intelicure Lifesciences, Ikeda Corporation
Which Regions Will Dominate the Carbapenem-Based Antibiotics Market Through 2029?
North America was the largest region in the Carbapenem-Based Antibiotics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the carbapenem-based antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12035
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Speak With Our Expert:
Saumya Sahay
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email:saumyas@tbrc.info
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Bacterial Infections And The Surge In Demand For Carbapenem-Based Antibiotics Is A Driving Force In Market Expansion Emerges as a Core Driver of the Carbapenem-Based Antibiotics Market in 2025 here
News-ID: 4182313 • Views: …
More Releases from The Business Research Company
Top Players and Competitive Environment in the Carbon Dioxide Recycling Methanol …
The carbon dioxide recycling methanol market is poised for remarkable expansion as the world intensifies efforts toward sustainability and carbon neutrality. With increasing emphasis on reducing greenhouse gas emissions and boosting renewable energy sources, this market is set to play a pivotal role in the global transition to cleaner fuels and circular carbon economies. Here's a detailed look at its projected growth, influential players, emerging trends, and segmentation.
Forecasted Market Growth…
Emerging Sub-Segments Transforming the Caprolactam Market Landscape
The caprolactam market is set for significant expansion in the coming years, driven by evolving industrial needs and sustainability initiatives. This report delves into the anticipated growth, key players, emerging trends, and detailed market segmentation to offer a comprehensive view of the sector's future trajectory.
Caprolactam Market Size Forecast Through 2030
The caprolactam market is projected to reach a value of $24.38 billion by 2030, growing at a compound annual…
Emerging Growth Patterns Driving Expansion in the Butyl Acrylate Market
The butyl acrylate market is gaining considerable attention as industries increasingly seek versatile chemical compounds to enhance their products. With its broad utility across coatings, adhesives, and textiles, the market is set for significant growth in the coming years. Let's explore the current market size, the main players, key trends, and segment insights shaping this industry.
Projected Market Size and Growth in Butyl Acrylate
The butyl acrylate market is poised…
In-Depth Examination of Segments, Industry Trends, and Key Competitors in the Bo …
Boron nitride coatings are gaining increased attention due to their versatile applications and enhanced protective qualities. As industries like automotive, aerospace, and electronics evolve, the demand for advanced coating solutions that can withstand extreme conditions is rising. This overview explores the current market size, key players, important trends, and dominant segments shaping the boron nitride coatings market.
Strong Market Growth Expected for Boron Nitride Coatings by 2030
The boron nitride…
More Releases for Antibiotics
Animal Feed Antibiotics Market Size and Share Forecast Outlook 2025 to 2035 : Gr …
The global animal feed antibiotics market is projected for significant expansion, with a market size of USD 2.9 billion in 2025 set to reach USD 4.4 billion by 2035, exhibiting a Compound Annual Growth Rate (CAGR) of 4.2%. This robust growth is primarily fueled by the escalating global demand for animal protein, advancements in feed additive technologies, and an increasing focus on livestock health management.
The market's trajectory is underscored by…
Emerging Trends Influencing The Growth Of The Veterinary Antibiotics Market: Col …
The Veterinary Antibiotics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
How Big Is the Veterinary Antibiotics Market Size Expected to Be by 2034?
Recent years have seen a swift expansion in the market size of veterinary antibiotics. It is projected to skyrocket from $2.47 billion…
Ruminant Feed Antibiotics Market Customization Available
The use of animal antibiotics has emerged as a critical component of the animal welfare program, which is increasing the adoption rate of animal antibiotics. The widespread adoption of the adage "prevention is better than cure" in the field of animal welfare is increasing the vigour of animal antibiotics.
Full Access Of Report:
https://www.databridgemarketresearch.com/reports/global-ruminant-feed-antibiotics-market
Top Trending Report:
https://predatascience1234.blogspot.com/2023/08/pyruvate-kinase-pk-deficiency-market.html
https://predatascience1234.blogspot.com/2023/08/quark-and-fromage-frais-market-size.html
https://predatascience1234.blogspot.com/2023/08/returnable-pallets-packaging-market.html
Data Bridge Market Research analyses that ruminant feed antibiotics market was valued at USD 4.7 billion in…
Antibiotics Market
The antibiotics market is anticipated to expand at a CAGR of over 4% during the forecast period. The antibiotic industry is expected to show substantial growth during the forecast period. However, unnecessary use of antimicrobials is often cited as up to 50% and misuse of antimicrobials is risky to patients. Giving antibiotics when required can be lifesaving, however, giving patients antibiotics when they are not needed creates preventable harm. It…
Antibiotics Market - Battling Superbugs: Cutting-Edge Antibiotics for Resistant …
Newark, New Castle, USA: The "Antibiotics Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Antibiotics Market: https://www.growthplusreports.com/report/antibiotics-market/7752
This latest report researches the industry structure, sales, revenue, price and…
Cephalosporin Antibiotics API market: Key Tactics by Players to Consolidate Pres …
"
The Cephalosporin Antibiotics API global market is thoroughly researched in this report, noting important aspects like market competition, global and regional growth, market segmentation and market structure. The report author analysts have estimated the size of the global market in terms of value and volume using the latest research tools and techniques. The report also includes estimates for market share, revenue, production, consumption, gross profit margin, CAGR, and other key…
